Managing viral infections effectively requires timely intervention and the right medication. For patients at risk of or affected by cytomegalovirus (CMV) infections, VOLANE SOURCE 450, containing Valganciclovir Tablet IP 450 mg, provides a potent antiviral solution. Manufactured by Steris Healthcare Pvt. Ltd., this medication is designed to prevent and treat CMV infections in immunocompromised individuals, including organ transplant recipients and patients with weakened immune systems.
What is VOLANE SOURCE 450?
VOLANE SOURCE 450 is an oral antiviral medication formulated with Valganciclovir 450 mg, a prodrug of ganciclovir. Upon administration, Valganciclovir is converted into ganciclovir in the body, which inhibits viral DNA replication. This mechanism effectively prevents the proliferation of cytomegalovirus, reducing infection severity and supporting patient recovery.
The oral formulation allows for convenient administration, making it suitable for long-term therapy or prophylactic use in high-risk patients.
How VOLANE SOURCE 450 Works
Valganciclovir works by targeting viral DNA polymerase, an enzyme critical for CMV replication. After absorption, Valganciclovir converts into ganciclovir, which incorporates into the viral DNA chain. This incorporation halts DNA synthesis, preventing the virus from multiplying and spreading.
By controlling viral replication, VOLANE SOURCE 450 helps prevent CMV-related complications, including retinitis, pneumonia, colitis, and systemic infections, particularly in immunocompromised patients.
Uses of VOLANE SOURCE 450
VOLANE SOURCE 450 is prescribed for:
Treatment of CMV infections: Effective in treating CMV retinitis in patients with AIDS and systemic CMV infections in immunocompromised individuals.
Prevention of CMV infection: Used prophylactically in organ transplant recipients kidney, heart, liver to reduce the risk of CMV-related complications.
Support for high-risk patients: Helps manage viral load and prevent severe complications in patients with weakened immune systems.
This medication is intended for use under medical supervision, with dosage adjusted based on renal function and patient-specific factors.
Benefits of VOLANE SOURCE 450
Effective Antiviral Action: Inhibits CMV replication, reducing viral load and infection severity.
Convenient Oral Therapy: Allows patients to take medication at home, improving adherence and comfort.
Prevention and Treatment: Suitable for both prophylaxis and active infection management.
Optimized Dosage: 450 mg strength provides a clinically effective dose for most adult patients.
Trusted Quality: Manufactured under strict quality control to ensure safety, potency, and consistency.
Why Choose VOLANE SOURCE 450 by Steris Healthcare?
Steris Healthcare Pvt. Ltd. is renowned for its commitment to quality, safety, and patient-centric formulations. Choosing VOLANE SOURCE 450 ensures:
Premium Manufacturing: Produced in GMP-certified facilities with strict quality assurance.
Trusted Brand: Steris Healthcare has decades of experience in providing reliable pharmaceutical solutions.
Scientifically Formulated: Ensures effective antiviral activity while minimizing side effects.
Patient-Focused Design: Oral formulation for convenient administration and long-term adherence.
Professional Support: Steris Healthcare provides guidance and support for patients and healthcare providers.
Dosage and Administration
Treatment: Typical adult dosage is 900 mg daily, divided into two 450 mg doses, or as prescribed by the doctor.
Prevention (Prophylaxis): Commonly prescribed as 450 mg once daily for organ transplant patients, adjusted based on kidney function.
Swallow tablets whole with water; do not crush or chew.
Take with food to enhance absorption and reduce gastrointestinal discomfort.
Renal function should be monitored, and dosage adjusted accordingly.
Safety and Precautions
Medical Conditions: Inform your doctor if you have kidney disease, low white blood cell counts, or liver issues.
Pregnancy and Lactation: Use only under medical supervision; safety during pregnancy and breastfeeding should be evaluated by a healthcare provider.
Common Side Effects: May include nausea, diarrhea, headache, fever, and mild fatigue.
Serious Side Effects: Rarely, it may cause neutropenia, anemia, or thrombocytopenia. Regular blood tests are recommended during treatment.
Drug Interactions: Avoid concomitant use with other nephrotoxic or bone marrow-suppressing medications without doctor consultation.
Patient Perspective
Patients taking VOLANE SOURCE 450 often report:
Effective prevention of CMV infections after organ transplantation
Reduction in viral load and improved overall health
Convenient oral administration for home use
Enhanced confidence in managing post-transplant complications or CMV infections
Improved quality of life due to reliable antiviral protection
By providing both treatment and prophylaxis, VOLANE SOURCE 450 empowers patients to manage their health proactively.
Frequently asked questions
Q1: Can VOLANE SOURCE 450 be used long-term?
A: Yes, under medical supervision, especially for prophylaxis in transplant patients. Regular monitoring is essential.
Q2: How soon does it work?
A: The onset depends on the patient’s viral load; blood tests help monitor effectiveness.
Q3: Can it be taken with food?
A: Yes, taking it with food improves absorption and reduces gastrointestinal discomfort.
Q4: Is dosage adjustment needed in kidney disease?
A: Yes, dosage should be adjusted based on renal function. Your doctor will guide you.
Q5: What should I do if I miss a dose?
A: Take the missed dose as soon as possible. If it is close to your next scheduled dose, skip the missed dose—do not double up.
Conclusion
Cytomegalovirus infections can pose serious health risks, especially for immunocompromised individuals and organ transplant recipients. VOLANE SOURCE 450, containing Valganciclovir Tablet IP 450 mg, provides a reliable solution for both prevention and treatment of CMV infections.
Manufactured by Steris Healthcare Pvt. Ltd., this premium-quality antiviral ensures safety, efficacy, and patient-focused convenience. With its oral formulation, proven antiviral activity, and professional healthcare support, VOLANE SOURCE 450 empowers patients to manage CMV effectively, prevent complications, and maintain a healthier, more secure life.
For further information:
📩 Email: info@sterispharma.com / contact@sterispharma.com📞 Call/WhatsApp: 8209542042, 8824175417
👉 BUY NOW
